Real-time enrollment status for this sars-cov-2 clinical trial
Current Status
Recruiting
Checked: October 29, 2026 at 6:35 PM UTC
| NCT Number | NCT07808697 |
| Recruiting Status | Recruiting |
| Condition | SARS-CoV-2 |
| Phase | PHASE2 |
| Target Enrollment | 300 participants |
| Active Locations | 13 sites in the US |
| Sponsor | ModernaTX, Inc. |
| Last Updated on CT.gov | October 29, 2026 (18 hours ago) |
As of October 29, 2026: Clinical trial NCT07808697 is currently recruiting participants. This phase2 study for sars-cov-2 is actively seeking new participants at 13 locations across the United States. The study is sponsored by ModernaTX, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07808697 is actively recruiting participants as of October 29, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 13 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07808697 was last updated 18 hours ago (October 29, 2026). HelloStudys verifies this status automatically.